Search research articles
Contact Us
Filters
Showing results (201-210 of 230) with videos related to
Page
of 23
Sort By:
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2024
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
Xiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.
Annals of Surgical Oncology
|
April 10, 2022
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal
ChuanLiang Cui, Bin Lian, XiaoShi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Jiayi Yu, Junya Yan, Qian Guo, et al.
Journal of the American Academy of Dermatology
|
September 8, 2022
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis
Xiaoting Wei, Yu Chen, Hong Yao, et al.
Nature Communications
|
May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma
Lili Mao, Yumei Lai, Hong Zheng, et al.
JAAD International
|
March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study
Xue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
JAMA Oncology
|
June 1, 2023
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
Lili Mao, Bin Lian, Caili Li, et al.
Annals of Surgical Oncology
|
April 8, 2020
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma
Xiaoting Wei, Di Wu, Hang Li, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
Ling-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 230) with videos related to
Sort By:
Page
of 23
Journal for Immunotherapy of Cancer
|
January 2, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 13, 2024
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
Xiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.
Annals of Surgical Oncology
|
April 10, 2022
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal
ChuanLiang Cui, Bin Lian, XiaoShi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 4, 2019
Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Jiayi Yu, Junya Yan, Qian Guo, et al.
Journal of the American Academy of Dermatology
|
September 8, 2022
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis
Xiaoting Wei, Yu Chen, Hong Yao, et al.
Nature Communications
|
May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma
Lili Mao, Yumei Lai, Hong Zheng, et al.
JAAD International
|
March 19, 2024
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study
Xue Bai, Aleigha R Lawless, Juliane A Czapla, et al.
JAMA Oncology
|
June 1, 2023
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
Lili Mao, Bin Lian, Caili Li, et al.
Annals of Surgical Oncology
|
April 8, 2020
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma
Xiaoting Wei, Di Wu, Hang Li, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial
Ling-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Page
of 23